96 related articles for article (PubMed ID: 20694697)
1. A scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening.
Wang Y; Jones P
Methods Mol Biol; 2009; 572():247-59. PubMed ID: 20694697
[TBL] [Abstract][Full Text] [Related]
2. A novel scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening.
Wang Y; Xu J; Uveges A; Ramarao MK; Rogers KE; Jones PG
Anal Biochem; 2006 Jul; 354(1):35-42. PubMed ID: 16707086
[TBL] [Abstract][Full Text] [Related]
3. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening.
Ramarao MK; Murphy EA; Shen MW; Wang Y; Bushell KN; Huang N; Pan N; Williams C; Clark JD
Anal Biochem; 2005 Aug; 343(1):143-51. PubMed ID: 16018870
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG
J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367
[TBL] [Abstract][Full Text] [Related]
5. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
Berry J; Price-Jones M; Killian B
Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase.
Scott CW; Tian G; Yu XH; Paschetto KA; Wilkins DE; Meury L; Cao CQ; Varnes J; Edwards PD
Eur J Pharmacol; 2011 Sep; 667(1-3):74-9. PubMed ID: 21645511
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency.
Tian G; Paschetto KA; Gharahdaghi F; Gordon E; Wilkins DE; Luo X; Scott CW
Biochemistry; 2011 Aug; 50(32):6867-78. PubMed ID: 21728345
[TBL] [Abstract][Full Text] [Related]
8. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
10. Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening.
Khawaja XZ
Anal Biochem; 2007 Jul; 366(1):80-6. PubMed ID: 17482135
[TBL] [Abstract][Full Text] [Related]
11. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J
Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889
[TBL] [Abstract][Full Text] [Related]
12. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
13. Development of fragment-based n-FABS NMR screening applied to the membrane enzyme FAAH.
Lambruschini C; Veronesi M; Romeo E; Garau G; Bandiera T; Piomelli D; Scarpelli R; Dalvit C
Chembiochem; 2013 Sep; 14(13):1611-9. PubMed ID: 23918626
[TBL] [Abstract][Full Text] [Related]
14. A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors.
Gevi M; Domenici E
Anal Biochem; 2002 Jan; 300(1):34-9. PubMed ID: 11743689
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Walker MC; Schweitzer BA; Madsen HM; Tenbrink RE; McDonald J; Smith SE; Foltin S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6538-44. PubMed ID: 21924614
[TBL] [Abstract][Full Text] [Related]
17. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
18. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.
Kage KL; Richardson PL; Traphagen L; Severin J; Pereda-Lopez A; Lubben T; Davis-Taber R; Vos MH; Bartley D; Walter K; Harlan J; Solomon L; Warrior U; Holzman TF; Faltynek C; Surowy CS; Scott VE
J Neurosci Methods; 2007 Mar; 161(1):47-54. PubMed ID: 17083980
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
20. High-throughput scintillation proximity assay for stearoyl-CoA desaturase-1.
Tawa P; Falgueyret JP; Guiral S; Isabel E; Powell DA; Zuck P; Skorey K
J Biomol Screen; 2011 Jun; 16(5):506-17. PubMed ID: 21406617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]